安必平:2025年净利润亏损4497.17万元

Core Viewpoint - Anbiping reported a significant decline in revenue and a net loss for the fiscal year 2025, primarily due to the implementation of national centralized procurement policies affecting product pricing [1] Financial Performance - The total operating revenue for the fiscal year 2025 was 347 million yuan, representing a year-on-year decrease of 26.24% [1] - The net profit for the period was a loss of 44.971 million yuan, compared to a net profit of 21.2913 million yuan in the same period last year [1] Business Impact - The revenue from the HPV product line decreased by approximately 46.5 million yuan due to a significant drop in pricing as a result of the national procurement policy [1]

LBPMedicine-安必平:2025年净利润亏损4497.17万元 - Reportify